Rapid Diagnostic Tests for Antimicrobial Resistance: Comparability of Results and Interpretation of Data

Similar documents
Investigational New Drug - Groundwork for in vitro antimicrobial susceptibility testing

National Center for Emerging and Zoonotic Infectious Diseases The Role of Breakpoint Committees for New Drugs Perspectives from the United States

Antibiotic Susceptibility Testing (ABST/AST)

ISO INTERNATIONAL STANDARD

Antibiotic Susceptibility Testing and Data Interpretation

A Verification Study for Implementing the Revised CLSI Breakpoints. Summary. Breakpoint Differences Cephalosporin Breakpoints for Enterobacteriaceae

A Verification Study for Implementing the Revised CLSI Breakpoints. Summary. Glossary CDC 1

This document is a preview generated by EVS

PERANAN MIKROBIOLOGI DALAM DIAGNOSIS PENYAKIT INFEKSI. dr. Agus Eka Darwinata, Ph.D.

ISO 15189:2012 and Susceptibility Testing BSAC User Day 22 June 2016

Cut-off Values and Species-Specific Breakpoints 12/19/2016

Setting Clinical Breakpoints/ECOFFS

Verification of Gradient Diffusion Strips

M. Ben-David 1, O. Hammer 1, A.Shinderman 1, Y. Gluckman- Yavo 1, M. Fridman 1, D. Gohman 1, G. Ingber 1 and E. Zahavy 2

Verification of Disk Diffusion Tests

Combatting AMR: diagnostics

Ezy MIC Strip FEATURES AND ADVANTAGES

Screening for Resistant Organisms and Infection Control

Susceptibility Tests

Antimicrobial Susceptibility Testing Method User Day

IMPLEMENTATION OF EUCAST BREAKPOINTS

ABC. Methods for Determining Bactericidal Activity of Antimicrobial Agents; Approved Guideline. Volume 19 Number 18

BSAC Susceptibility Testing Residential Workshop

M. Ben-David 1, O. Hammer 1, A.Scinderman 1, Y. Gluckman-Yavo 1, M. Fridman 1, D. Gohman 1, G. Ingber 1 and E. Zahavy 2

Dr. Rukumani Devi Velayuthan Mycology Unit Co-ordinator PPUM

Antimicrobial Susceptibility Testing

Empfindlichkeitstestung bei Pilzen Neuigkeiten? Bericht aus einem EUCAST AFST (yeasts and moulds) Netzwerk-Laboratorium

Validation of the Automated Reading and Incubation System with Sensititre Plates for Antimicrobial Susceptibility Testing

Shionogi Presents Results of the First Clinical Efficacy Trial and In Vitro Data on Cefiderocol (S ), a Siderophore Cephalosporin

CRE Laboratory Testing and CRE Lab Testing Recommendations in-depth recommendations on CRE laboratory detection

CLINICAL MICROBIOLOGY HOSPITAL LABORATORY PRACTICE

Outline. Introduction. Broth and Agar testing methods Automated susceptibility testing. Aims of antimicrobial susceptibility testing:

Antimicrobial Susceptibility Testing Paradigms: Current Status and Future Directions

Biofilm Protocol Optimization For Pseudomonas aeruginosa. Introduction. Materials and Methods. Culture Media, Incubation Time, and Biofilm Measurement

Abstract. Mary Jane Ferraro, PhD, MPH Jana M. Swenson, MMSc

Inside the Burch Lab: E. Coli and Triclosan Resistance. By: Pamela Lammonds

BSAC Susceptibility Testing Residential Workshop

Adopting EUCAST breakpoints in countries currently on CLSI breakpoints

BSAC Susceptibility Testing Testing Residential Workshop Residential Workshop

Terminology relating to methods for the determination of susceptibility of bacteria to antimicrobial agents

Pharmacodynamics of Ampicillin-Sulbactam in an In Vitro Infection Model against Escherichia coli Strains with Various Levels of Resistance

NordicAST Bacteroides AST Study 2018

Use of Molecular Assays for Resistance Detection

NEXT STEP TO STOP THE SPREAD OF ANTIMICROBIAL RESISTANCE. Patricia Ruiz Garbajosa Servicio de Microbiología Hospital Universitario Ramón y Cajal

Can whole genome sequencing replace AST?

by author How to effectively report laboratory findings to clinicians (Breakpoints and Interpretation)

2015 EDITION. Selection. Publications. FAN Plus Media

Disk Diffusion Method for Susceptibility Testing of

ESCMID Online Lecture Library. by author

testing for the daily routine?

Validation and Reproducibility Assessment of Tigecycline MIC Determinations by Etest

Determination of Penicillin MICs for Streptococcus pneumoniae by Using a Two- or Three-Disk Diffusion Procedure

NCCLS Standards for Antimicrobial Susceptibility Tests

Approximately 20% of the responding CLSI membership whose hospitals had greater than 200 beds was performing antifungal testing.

Title:Detection of antibiotic resistance in probiotics of dietary supplements

Transmission Electron Microscopic Study of Antibiotic Action on Klebsiella pneumoniae Biofilm

DEPARTMENT OF CLINICAL LABORATORY SCIENCES SCHOOL OF HEALTH TECHNOLOGY AND MANAGEMENT THE UNIVERSITY AT STONY BROOK STONY BROOK, NEW YORK

Lauren A. Darling1#, Ann M. Evans1, Kathleen A. Stellrecht1,2, Seela M. Nattanmai1,

BACTERIAL CONJUGATION. To demonstrate the technical procedure to monitor the conjugational transfer of genetic material from one cell to another.

Ten Minute, Reagent-Free identification of Bacteria Containing Resistance Genes Using a Rapid Intrinsic Fluorescence Method

Supplementary Information for

Association of gyra mutation in Mycobacterium tuberculosis isolates with phenotypic ofloxacin resistance detected by resazurin microtiter assay

Determination of MIC & MBC

Determination of MIC & MBC

Updating Antimicrobial Susceptibility Testing Methods

Updating Antimicrobial Susceptibility Testing Methods

Direct Susceptibility Testing with Positive BacT/Alert Blood Cultures by Using MicroScan Overnight and Rapid Panels

Direct Susceptibility Testing with Positive BacT/Alert Blood Cultures by Using MicroScan Overnight and Rapid Panels

Direct Susceptibility Testing with Positive BacT/Alert Blood Cultures by Using MicroScan Overnight and Rapid Panels

Finding the Bugs through EQA

Advances in Medical Microbiology - Are the Patients Better Off?

generated by the usage of antimicrobial drugs is absent. She is the author of 14 publications in international journals.

ESCMID Online Lecture Library. by author

SAMPLE. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically

VanABC plus. GENSPEED VanABC plus. Molecular multiplex assay for maximum information.

Introduction. Results

Klebsiella and Raoultella biotyping and probability of identification by Vitek-2 system

Comparison of BD Phoenix to Vitek 2, MicroScan MICroSTREP, and Etest for Antimicrobial Susceptibility Testing of Streptococcus pneumoniae

Carbapenem-resistant Enterobacteriaceae (CRE): Surveillance and Response. David Selvage, MHS, PA-C New Mexico Department of Health March 15, 2016

Comparison of different methods of determining b-lactam susceptibility in clinical strains of Pseudomonas aeruginosa

EM021. Co-Trimoxazole Ezy MIC TM Strip (COT)( mcg/ml) (Trimethoprim/ Sulphamethoxazole) Antimicrobial Susceptibility Testing

Case. Case. Case. Case. Reference lab AST. Nelesh Govender, NICD 2013/03/08. Candida species: Antifungal susceptibility testing in 2013

BIOMIC V3 Microbiology System Product Specifications

Laboratory Detection of Carbapenemase-producers

Comparison of the BD Phoenix with the Vitek 2, MicroScan MICroSTREP, and Etest for Antimicrobial Susceptibility Testing of Streptococcus pneumoniae

Comparison of the BD Phoenix with the Vitek 2, MicroScan MICroSTREP, and Etest for Antimicrobial Susceptibility Testing of Streptococcus pneumoniae

Johan W Mouton Canisius-Wilhelmina Hospital Nijmegen, The Netherlands

by author ESCMID Online Lecture Library Implementation of EUCAST antimicrobial susceptibility testing methods Gunnar Kahlmeter, Derek Brown

Are There Non-Carbapenem β-lactam Options for Treating ESBL Infections?

2120 Lab. Week 11. Experiments 13,14,21. Kirby Bauer, TDT, Chemicals

The University of Jordan

Minireview: CLSI Methods Development and Standardization Working Group Best Practices for

Activity of meropenem and other antimicrobial agents against uncommon Gram-negative organisms

International harmonization of breakpoints is it possible? Gunnar Kahlmeter EUCAST, CLSI

and Product Protection Process

Meropenem: in-vitro activity and kinetics of activity against organisms of the Bacteroides fragilis group

R IC H A R D C. T IL T O N, Ph.D. A N D L IN D A L IE B E R M A N, B.S.

Evaluation of the Carba NP Test for the Detection of Carbapenemase Activity in Bacteroides Species

1. Procedure for Antibiotic susceptibility test by disc diffusion analysis

Transcription:

Rapid Diagnostic Tests for Antimicrobial Resistance: Comparability of Results and Interpretation of Data Christopher Teale, Animal and Plant Health Agency, UK. 12 th OIE One-Day Seminar, in association with the World Association of Veterinary Laboratory Diagnosticians, June 2017.

Susceptibility Testing - comparability of results. The reference (gold standard) method against which results should be compared. The inherent variation of the test methodology category agreement and essential agreement. Test parameters Sensitivity Specificity Very major errors Major errors Clinical predictive value Sources of Information. 2

Susceptibility Testing interpretation of data. Test parameters Sensitivity Specificity Very major errors Major errors Clinical predictive value Complicating factors 3

Sources of Information: International Organization for Standardization (ISO). Clinical Laboratory Testing and In Vitro Diagnostic Test Systems. Susceptibility Testing of Infectious Agents and Evaluation of Performance of Antimicrobial Susceptibility Test Devices. Part 2: Evaluation of performance of antimicrobial susceptibility test devices. International Standard 20776-2. Geneva, Switzerland. 2007. Guidance for Industry and FDA. Class II Special Controls Guidance Document: Antimicrobial Susceptibility Test (AST) Systems. Document issued on: August 28, 2009 http://www.fda.gov/medicaldevices/deviceregulationandguidance/guidance Documents/ucm080564.htm. National susceptibility testing committees.

Reference method broth dilution determination of minimum inhibitory concentration (MIC). Reference method (ISO 20776-1). ISO 20776-1 (2006). Clinical laboratory testing and in vitro diagnostic test systems Susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility test devices Part 1: reference method for testing the in vitro activity of antimicrobial agents against rapidly growing aerobic bacteria involved in infectious diseases. Available at www.iso.org/iso/iso_catalogue_detail.htm?csnumber=41630.

Minimum Inhibitory Concentration. Broth Dilution MIC. Antimicrobial concentration 6 0.25 0.5 1 2 4 8 16 Final inoculum usually 10 5 cfu/ml in broth, 10 4 cfu/ spot on solid media. The MIC is defined as the lowest concentration of antibiotic at which there is no visible growth of the organism.

Complicating Factors: Detection of resistance genes that are not expressed. Complex regulation of resistance gene expression. Inducible resistance Constitutive resistance Variation in the regulation of a resistance mechanism efflux pumps. The selection of isolates included in the panel tested.

Complicating Factors: Inducible resistance only expressed in the presence of an inducing antimicobial. Consititutive resistance expressed permanently.

Features of the MIC distribution (from EUCAST):

In fact, repeatedly testing the SAME isolate gives the same WT distribution:

Inherent Variation in the Reference Test Methodology ESSENTIAL AGREEMENT. There is inherent variation in the reference test method. This can be at least partly accounted for in test comparisons by use of the term essential agreement. MIC result obtained by new method which is within one dilution of the result obtained by the reference method. Number with essential agreement x 100 Total number examined

Features of the MIC distribution (from EUCAST): Breakpoint R > 0.5 clearly separates resistant and wild-type susceptible populations.

Features of the MIC distribution (from EUCAST): If the breakpoint was > 0.06 and split the wildtype population, you could not clearly and consistently separate resistant and susceptible populations because of the inherent test variation.

Category Agreement. Examines agreement between sensitive/ intermediate/ resistant results with the reference method. Number of isolates with category agreement x 100 Total number tested.

Essential Agreement an example. Cantón et al. Journal of Clinical Microbiology, 38, 1339-1346 (2000) Compared an identification and susceptibility testing system with broth microdilution. Overall essential agreement (± 1 log 2 dilution) for 3,719 organism / antimicrobial combinations was 95.6% Essential agreement was calculated for groups of organisms studied (88.0% for non-fermentative Gram-negative rods). Essential agreement was calculated for groups of organisms and individual antimicrobials (84.0% for Enterobacteriaceae versus imipenem). >-2-2 -1 0 +1 +2 >+2 Ampicillin 0 0 2.1 97.8 0 0 0 Amox/clav 0 0.7 7.9 85.5 3.6 1.4 0.7 Text in footer 15

Category Agreement an example. Shio-Shin et al. (2014) Journal of Microbiology, Immunology and Infection (2015). Evaluation of susceptibility of clinical isolates of Enterobacteriaceae and nonfermentative Gram-negative bacilli to cefoperazone/ sulbactam. Used agar dilution as the reference method and compared disc diffusion and two automated systems against it. E. coli (N=150) categorical agreement for cefoperazome-sulbactam: Categorical agreement Disc Diffusion 97.3 Automated system 1 97.3 Automated system 2 84 Text in footer 16

Sensitivity and Specificity. Sensitivity is the proportion of true positives correctly identified by the test. Specificity is the proportion of true negatives identified by the test. Provide one of the approaches to quantifying the diagnostic ability of a test. May be applied to assess degree of categorical agreement (non-susceptible versus susceptible) of different methods.

Examples from the literature Cunningham et al. (2017) Journal of Clinical Microbiology 55, 1954-1960. Multicenter perfromance assessment of Carba NP test. Multi-centre assessment of Carba NP test hydrolysis of imipenem produces acid, affects a ph indicator. Genotype result (carbapenemase resistance gene detection) used as the gold standard. Specificity for all non-enterobacteriaceae was 100.0% at each of seven sites. Sensitivity 60.0 87.5% across seven sites. Text in footer 18

Sensitivity and Specificity. Shio-Shin et al. (2014) Journal of Microbiology, Immunology and Infection (2015). Evaluation of susceptibility of clinical isolates of Enterobacteriaceae and nonfermentative Gram-negative bacilli to cefoperazone/ sulbactam. Used agar dilution as the reference method and compared disc diffusion and two automated systems against it. E. coli (N=150) versus cefoperazome-sulbactam compared to reference method Sensitivity Specificity Disc Diffusion 100 98.6 Automated 1 88.9 99.3 Automated 2 44.4 87.2 Text in footer 19

Predictive Values. We need to know the probability that the test used will give us the correct diagnosis. Sensitivity and specificity don t provide this. Positive predictive value is the proportion of patients/ tests with positive / resistant results which are correctly diagnosed. Negative predictive value is the proportion of patients with negative / susceptible test results which are correctly diagnosed. Dependent on prevalence of item of interest; if rare can be more certain that negative result is negative, but less sure that positive result is positive Disc Diffusion Sensitivity Specificity Positive predictive value 100 98.6 81.8 100 Automated 1 88.9 99.3 88.9 99.3 Automated 2 44.4 87.2 18.2 96.1 Negative predictive value Text in footer 20

Errors. Used because there are particular features relevant to antimicrobial treatment. If the test result is susceptible but the organism is resistant, then the patient may die, because you may choose a treatment which may not work. If the test result is resistant, but the organism is susceptible, then the patient will not be given this antimicrobial and will (hopefully!) receive a suitable alternative and survive. These ideas are captured by Very major errors (also called very major discrepancy) Major errors (also called major discrepancy) Minor errors (also called minor discrepancy) Text in footer 21

Very Major Error/ Discrepancy. Reference test result resistant, method under comparison result sensitive. The patient might be inappropriately treated and die. Number of tests giving a very major error x 100 Number of bacteria resistant by reference method Text in footer 22

Major Error/ Discrepancy. Reference test result sensitive, method under comparison result resistant. The patient will not be inappropriately treated but the category result is wrong. Number of tests giving a major error x 100 Number of bacteria susceptible by reference method Text in footer 23

Minor Error/ Discrepancy. Reference test result intermediate, method under comparison result sensitive or resistant. Or vice versa. Number of tests giving a minor error x 100 Number of bacteria tested by reference method Text in footer 24

Errors/ Discrepancies. Advice levels are provided in some of the references mentioned earlier. Rates are set for what may be considered an acceptable error level in each category. ISO, quoted in Shio-Shin et al. (see earlier). Very Major Error < 1.5% Major Error < 3% Minor Error < 10% BSAC Very major error considered < 1% when setting breakpoints. Text in footer 25

Clinical Predictive Value. Clinical response of patient considering susceptible or resistant test result. Doern and Brecher, Journal of Clinical Microbiology 49, 9 supplement S11-S14. MIC Number of Patients % Cured or Improved % Eradication < 4 (S) ~1000 94 91 8 (S) ~250 90 86 16 (I) ~150 77 75 32 (I) 70 84 71 64 (R) 20 64 50 Text in footer 26

Thank you for listening Text in footer 27